Sign In
Buy DCPH
$25.59
+0 (+0%)
At Close: Sep 09, 2024
Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2023 Earnings Call Transcript
04:58am, Sunday, 07'th May 2023
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Jen Larson - Senior Vice President-Finance and Investor Relations Steve Hoer
Deciphera (DCPH) Q1 Earnings Match Estimates, Sales Miss
06:53am, Thursday, 04'th May 2023
Deciphera Pharmaceuticals (DCPH) reports mixed first-quarter 2023 results as its earnings are in line with the Zacks Consensus Estimate, while revenues miss the same.
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Lags Revenue Estimates
09:55am, Wednesday, 03'rd May 2023
Deciphera Pharmaceuticals, Inc. (DCPH) came out with a quarterly loss of $0.60 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.80 per share a year ago.
Deciphera Pharmaceuticals: In The Middle Of A Major Comeback (Upgrade)
08:00am, Saturday, 25'th Mar 2023
Last year, Deciphera Pharmaceuticals, Inc. was almost destroyed by a trial failure. This year, Deciphera Pharmaceuticals has demonstrated huge benefit in a subpopulation, and also progressed the rest
Deciphera Pharmaceuticals: INTRIGUE Phase 3 Shows Substantial Benefit
05:21am, Saturday, 18'th Mar 2023
Deciphera has a strong portfolio of investigational kinase inhibitors, including ripretinib, vimseltinib, and DCC-3116, that have demonstrated encouraging preliminary efficacy and safety data in treat
Why Deciphera Pharmaceuticals Stock Jumped This Week
05:25pm, Thursday, 16'th Mar 2023
Deciphera focuses on oncology therapies. The company's lead therapy is Qinlock, approved to treat patients with gastrointestinal stromal tumors.
Deciphera Pharmaceuticals, Inc. (DCPH) Soars 10.3%: Is Further Upside Left in the Stock?
06:07am, Tuesday, 14'th Mar 2023
Deciphera Pharmaceuticals, Inc. (DCPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into furt
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Down 7.1% Since Last Earnings Report?
12:57pm, Thursday, 09'th Mar 2023
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock?
Deciphera Pharmaceuticals, Inc. (DCPH) Q4 2022 Earnings Call Transcript
01:50pm, Tuesday, 07'th Feb 2023
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH ) Q4 2022 Earnings Conference Call February 7, 2023 8:00 AM ET Company Participants Jen Larson – Senior Vice President-Finance and Investor Relations Ste
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Tuesday, 07'th Feb 2023
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of -5.26% and 2.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for
Deciphera (DCPH) Issues Strategic & Corporate Outlook for 2023
01:32pm, Wednesday, 04'th Jan 2023
Deciphera (DCPH) provides a strategic outlook and planned corporate milestones for 2023. The company also posts preliminary fourth-quarter and 2022 revenues.
Deciphera Pharmaceuticals, Inc. (DCPH) Q3 2022 Earnings Call Transcript
10:17am, Saturday, 05'th Nov 2022
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Jen Larson – Senior Vice President-Finance and Investor Relations Ste
Deciphera's (DCPH) Q3 Loss Narrows, Qinlock Drives Revenues
05:18pm, Friday, 04'th Nov 2022
Deciphera (DCPH) reports a narrower-than-expected loss for the third quarter of 2022 while revenues beat estimates. Qinlock drives year-over-year sales.
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q3 Loss, Tops Revenue Estimates
09:50am, Thursday, 03'rd Nov 2022
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 3.51% and 8.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for
Is Deciphera Pharmaceuticals (DCPH) Stock Outpacing Its Medical Peers This Year?
11:17am, Tuesday, 04'th Oct 2022
Here is how Deciphera Pharmaceuticals, Inc. (DCPH) and Jazz Pharmaceuticals (JAZZ) have performed compared to their sector so far this year.
